Extended release opioid abuse deterrent compositions and methods of making same

1. An extended release abuse deterrent dosage form comprising:

a. a core matrix comprising a blended mixture of:

(a) PEO having a molecular weight of from about 300,000 to about 5,000,000;

(b) magnesium stearate; and

(c) oxycodone or a pharmaceutically acceptable salt thereof;

wherein the matrix is heated to melt at least a portion of the PEO included in the matrix; and

b. PEG applied onto the core matrix;

wherein the dosage form provides extended release of the drug.